--- title: "Merck KGaA (MKKGY) Projected to Post Earnings on Thursday" type: "News" locale: "en" url: "https://longbridge.com/en/news/294317467.md" description: "Merck KGaA (MKKGY) is scheduled to release quarterly earnings before the market opens on Thursday, August 6. Analysts project earnings of $0.47 per share and revenue of $6.08 billion. This follows a previous quarter where the company beat estimates with $0.59 EPS. Recent analyst actions include Zacks Research upgrading the stock to 'strong-buy', while Jefferies and HSBC maintain 'hold' ratings. The stock currently trades around $32.91 with an average consensus rating of 'Hold'." datetime: "2026-07-30T07:11:34.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294317467.md) - [en](https://longbridge.com/en/news/294317467.md) - [zh-HK](https://longbridge.com/zh-HK/news/294317467.md) generator: "portal-rs" --- # Merck KGaA (MKKGY) Projected to Post Earnings on Thursday Merck KGaA (OTCMKTS:MKKGY - Get Free Report) is expected to issue its results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of $0.47 per share and revenue of $6.0806 billion for the quarter. Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last announced its earnings results on Wednesday, May 13th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.45 by $0.14. Merck KGaA had a net margin of 12.07% and a return on equity of 8.79%. The company had revenue of $6.03 billion during the quarter, compared to the consensus estimate of $5.93 billion. On average, analysts expect Merck KGaA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year. ## Merck KGaA Stock Down 0.2% Merck KGaA stock opened at $32.91 on Thursday. Merck KGaA has a fifty-two week low of $23.73 and a fifty-two week high of $34.19. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.00 and a current ratio of 1.51. The firm's 50-day simple moving average is $31.58 and its 200 day simple moving average is $29.05. The stock has a market cap of $21.27 billion, a PE ratio of 14.63, a price-to-earnings-growth ratio of 2.90 and a beta of 1.00. ## Analysts Set New Price Targets A number of brokerages recently commented on MKKGY. Zacks Research raised Merck KGaA from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, July 22nd. Jefferies Financial Group started coverage on Merck KGaA in a research note on Tuesday, May 26th. They issued a "hold" rating for the company. Finally, HSBC raised Merck KGaA to a "hold" rating in a research report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold". **Check Out Our Latest Report on Merck KGaA** ## About Merck KGaA (Get Free Report) Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY. Merck's Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility. ## Further Reading - Five stocks we like better than Merck KGaA - Why SK hynix Could Be the Best AI Chip Stock to Buy Now - Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters - Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead? - Why Bloom Energy May Be the Most Important AI Infrastructure Stock *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Merck KGaA Right Now? Before you consider Merck KGaA, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list. While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [MKKGY.US](https://longbridge.com/en/quote/MKKGY.US.md) - [MRK.DE](https://longbridge.com/en/quote/MRK.DE.md) - [JEF.US](https://longbridge.com/en/quote/JEF.US.md) - [HSBC.US](https://longbridge.com/en/quote/HSBC.US.md) - [MRK.US](https://longbridge.com/en/quote/MRK.US.md) - [STX.US](https://longbridge.com/en/quote/STX.US.md) - [GOOGL.US](https://longbridge.com/en/quote/GOOGL.US.md) - [GOOG.US](https://longbridge.com/en/quote/GOOG.US.md) - [BE.US](https://longbridge.com/en/quote/BE.US.md) - [DTIW.SG](https://longbridge.com/en/quote/DTIW.SG.md) - [00005.HK](https://longbridge.com/en/quote/00005.HK.md) - [HSBA.UK](https://longbridge.com/en/quote/HSBA.UK.md) ## Related News & Research - [DZ BANK AG Keeps Their Buy Rating on Merck KGaA (0O14)](https://longbridge.com/en/news/295290343.md) - [Merck KGaA (OTCMKTS:MKKGY) Short Interest Update](https://longbridge.com/en/news/293802891.md) - [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md) - [GMF LENS-Aggressive Treasury yield cap could weigh on dollar, says Citi's asset allocation head](https://longbridge.com/en/news/297345741.md) - [REG - APG Asset Management Prologis, Inc. - Form 8.3 - Prologis Inc](https://longbridge.com/en/news/297620884.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**